Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
Should you bet on an established giant or a pipeline-driven innovator? This comparison examines Amgen (NASDAQ:AMGN) and Moderna…
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
The recent breakout of Moderna reminded investors that AI stocks aren’t the only destination to make money. Healthcare…
Cancer treatment could face landmark moment with promising vaccine
The drug, intismeran autogene, treats melanoma, the deadliest form of skin cancer, of which the US National Cancer…
2 Healthcare Stocks That Could Soar Over the Next 5 Years
While the stock market is facing significant volatility right now, there is a decent chance it will still…
FDA plans bonuses to staffers who complete speedy drug reviews
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
FDA drug approvals: Makary and Prasad say one study will be enough
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
Moderna mRNA-based drug cut the risk of recurrence or death when combined with immunotherapy Keytruda
“Today’s results highlight the potential of a prolonged benefit of the intismeran autogene and Keytruda combination,” Kyle Holen,…
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
Moderna could tumble once again, if there’s a lack of positive news in its upcoming earnings release. Novo…